All Stories

  1. Role of acetylcholinesterase inhibitors in the management of Alzheimer's disease
  2. Enhancing Cancer Treatment Prognosis through AI-driven Immunotherapy Predictions
  3. Development of a Robust QSAR Model to Predict the Affinity of N-Bridged Bicyclic Sulfonamide, Pyrazole/Sulfonamide Based Dihydroquinoline and Sulfonamide –Pyrazolopiperidine γ-secretase Inhibitors
  4. An on-board journey from conventional to novel biomarkers for detection and monitoring of Alzheimer’s disease
  5. Secondary Plant Metabolites and their Role in Celiac Disease Management.
  6. Techniques and Strategies for Engineering Vaccine Adjuvants: A Comprehensive Review
  7. Acacia catechu: Comprehensive Review of Traditional Use, Phytochemicals and Pharmacology
  8. Sirtuin1: A Potential Key Regulator in Alzheimer's Disease Pathophysiology and Therapeutics
  9. An Overview of Synthesis and Characterization Techniques of Biopolymer Composites
  10. Formulation and Development of Sustained Release Floating Tablets of Metformin Hydrochloride
  11. Design of Novel Acat Inhibitors as Potent Anti-Hyperlipidemic Agents Using Chemometric Approaches
  12. Herbal based nanoparticles as a possible and potential treatment of cancer: a review
  13. Extraction and Characterization of Natural Polymers for Pharmaceutical Use
  14. In Silico Efficacy of Oleic Acid, n-Hexanoic acid, and Epiglobulol Obtained from Conocarpus Lancifolius against Class D β-lactamases
  15. Nyctanthes arbor-tristis Improves Blood Pressure via Endothelial Pathway: In Silico, Ex Vivo, and In Vivo Evidence
  16. Aminopeptidase A: A Novel Therapeutic Target for Hypertension Management
  17. Marine Metabolites Targeting Inflammatory and Autoimmune Diseases
  18. Marine Natural Products
  19. A Review on Tablet in Tablet for Cancer and Use of ArtificialIntelligence (AI)
  20. Decoding the molecular Symphony: Unravelling neurologically crucial GSK-3 inhibition through 2D QSAR modelling with MLR, PLS, and ANN approaches
  21. Quantitative Structure Activity Relationship Studies of Potent Endothelin-A Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension